EUVIMED · CrossrefZeitschrift
Advances in Alzheimer's Disease
ISSN 2169-2459 · Scientific Research Publishing, Inc.
Neueste Artikel
A Risk Coefficient for Radiation-Induced Dementia
Neuroprotective Effect of <i>Phyllanthus acidus</i> L. on Learning and Memory Impairment in Scopolamine-Induced Animal Model of Dementia and Oxidative Stress: Natural Wonder for Regulating the Development and Progression of Alzheimer’s Disease
Human butyrylcholinesterase knock-out equivalent: Potential to assess role in Alzheimer’s disease
Gabapentin for the treatment of behavioral and psychological symptoms of dementia
Gender differences in anxiety and depression among the caregivers of patients with dementia
Spatial structure of beta-amyloid Aβ<sub>1-40</sub> in complex with a biological membrane model
CSF tau and amyloid β<sub>42</sub> levels in Alzheimer’s disease—A meta-analysis
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias
Comparison of protein concentrations in serum versus plasma from Alzheimer’s patients
Paradoxical prosopagnosia in semantic dementia
Certain new aspects of etiology and pathogenesis of Alzheimer’s disease
Understanding the individual with Alzheimer’s disease: Can socioemotional selectivity theory guide us?
Neuronal protection by a variant of GAPDH pseudogene P44 in AD
Tyrosine kinase receptor B isoforms alter APP and BACE1 endogenous levels independently of BDNF
Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia
Medial temporal lobe volume predicts rate of learning in Rey-AVLT
Biomarkers for the early diagnosis of Alzheimer’s disease: The challenge of XXI century
Leptin rescues neurons from Alzheimer’s disease-related pathways triggered by lipid burden
Early onset versus late onset in Alzheimer’s disease: What is the reliable cut-off?
Advances in Alzheimer’s disease (AAD): Standing firm at its first anniversary
The evaluation of iron content in Alzheimer’s disease by magnetic resonance imaging: Phase and R2* methods
The role of APP in Alzheimer’s disease
Evaluation of the inhibitory effect of docosahexaenoic acid and arachidonic acid on the initial stage of amyloid β1-42 polymerization by fluorescence correlation spectroscopy
Letter to the Editor
Predictors of hospitalization and institutionalization in Medicaid patient populations with Alzheimer’s Disease
Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial
S100b protects IMR-32 cells against Ab(1-42) induced neurotoxicity via modulation of apoptotic genes expression
Calcineurin overexpression regulates APP metabolism
BLMH and APOE genes in Alzheimer Disease: A possible relation
Cognitive assessment in Alzheimer’s disease
EUVIMED